FDA authorizes Novavax's updated COVID vaccine for fall 2023
Published
The Food and Drug Administration announced Tuesday it had authorized Novavax's updated COVID-19 vaccine, adding a third option for Americans ages 12 and older looking for a new shot this fall and winter. Novavax's updated shot has been redesigned to target the XBB strains of the virus, similar to…
#novavax #xbb #moderna #pfizer #johnjacobs #fda #petermarks #cdc #bridgeaccess #vaccinesforchildren